Related Experiment Videos
T lymphocyte activation and restenosis after percutaneous transluminal coronary angioplasty
12nd Department of Internal Medicine, Yamanashi Medical University, Nakakoma-gun, Yamanashi, Japan. osadam@res.yamanashi-med.ac.jp
Insights
Elevated soluble interleukin-2 receptor (sIL-2R) levels after percutaneous transluminal coronary angioplasty (PTCA) indicate T lymphocyte activation and predict restenosis risk in stable angina patients.
Area of Science:
- Cardiology
- Immunology
- Biomarkers
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) can trigger an inflammatory response.
- Restenosis, the re-narrowing of arteries, is a complication following PTCA.
- T lymphocyte activation is implicated in post-angioplasty inflammation and restenosis.
Purpose of the Study:
- To investigate the relationship between T lymphocyte activation and restenosis after PTCA.
- To assess soluble interleukin-2 receptor (sIL-2R) as a marker for T lymphocyte activation post-PTCA.
- To determine if sIL-2R levels can predict restenosis in patients with stable angina.
Main Methods:
- Studied 10 stable angina patients undergoing successful PTCA.
- Measured soluble interleukin-2 receptor (sIL-2R) levels before and 2 hours after PTCA.
- Performed 3-month follow-up coronary angiography to assess for restenosis.
Main Results:
- Four out of 10 patients developed restenosis.
- Patients with restenosis exhibited significantly higher post-PTCA sIL-2R levels (495 U/ml) compared to those without restenosis (274 U/ml).
- The difference in sIL-2R levels between the groups was statistically significant (p < 0.01).
Conclusions:
- sIL-2R is a potential prognostic marker for restenosis after elective PTCA.
- Elevated sIL-2R levels post-PTCA may identify patients at high risk for clinical restenosis.
- Monitoring sIL-2R could aid in risk stratification for restenosis following coronary angioplasty.
Abstract:
We investigated the relation between the activation of T lymphocytes and the occurrence of restenosis after percutaneous transluminal coronary angioplasty (PTCA) in 10 stable angina patients. Recent studies have suggested that PTCA causes an inflammatory response, which may affect restenosis after angioplasty. Soluble interleukin-2 receptor (sIL-2R) is a useful marker to evaluate the activation of T lymphocytes. sIL-2R was measured before and 2 h after successful PTCA, and 3-month follow-up coronary angiography was done to observe restenosis. Four of 10 patients showed restenosis. The restenosis group of 4 patients had a higher level of sIL-2R after PTCA than the no-restenosis group of 6 patients (495 vs. 274 U/ml, p < 0.01). This study suggests that sIL-2R may offer prognostic information after elective PTCA and identify a subgroup of patients at high risk for clinical restenosis in a few months.